Eating Disorders are serious psychiatric disorders associated with high rates of morbidity and mortality. Prevalence rates vary by sample and method of ascertainment. It is estimated that approximately 2.5% of the population in the US will have an eating disorder during their lifetime. Eating Disorders are described worldwide and are responsible for health care and disability-related costs that are estimated to total $400 billion annually in the US. Eating disorders are not new disorders and, despite myths to the contrary, do not affect only white adolescent females.
Anorexia nervosa was first described centuries ago; bulimia nervosa first entered the scientific literature 45 years ago and appears to be more prevalent in Hispanic/Latino and African-American populations than in non-Latino white individuals. Binge eating disorder, first introduced as a formal diagnostic category in DSM-5, was described as clinical problem for decades prior to DSM-5’s publication in 2013 and had garnered an extensive literature prior to formal diagnostic recognition. Another new label, Avoidant/Restrictive Food Intake Disorder (ARFID), was introduced in DSM-5, and has been a welcome addition; it describes a significant number of individuals with an eating problem characterized by limited eating that contributes to medical or psychosocial difficulty without the body shape and weight concerns typical of other eating disorders.
This presentation will review the current eating disorder diagnoses and what is known about presentation, treatment, and course of illness. Recent investigations into illness mechanisms will be described, with specific attention to the neurobiology of anorexia nervosa and mechanism-based treatments that are currently under development. The presentation will additionally describe new topics relevant to eating disorders identification and management, including Atypical Anorexia Nervosa (a condition defined as including all of the features of anorexia nervosa except for the presence of a significantly low body weight), ARFID, and the utility of medications in the management of eating disorders.
Format
Recorded webinar, non-interactive, self-paced distance learning activity.
This presentation was recorded at the 2024 American Psychiatric Association Annual Meeting.
Learning Objectives
- Accurately identify the Feeding and Eating Disorders, including Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder and Avoidant/Restrictive Food Intake Disorder
- Recognize that Eating Disorders affect all gender, ethnic and racial groups
- Identify Atypical Anorexia Nervosa, a DSM-5 label within the category of Other Specified Feeding and Eating Disorders (OSFED)
- Distinguish Avoidant/Restrictive Food Intake Disorder (ARFID) from other restrictive eating disorders and learn about treatments currently considered for use in ARFID
Target Audience
Medical Students, Residents/Fellows, Psychiatrists
Estimated Time to Complete
Estimated Duration: 1.5 hours
Begin Date: February 1, 2025
End Date: February 1, 2028
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the event date and hours earned.
Continuing Education Credit
In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The APA designates this enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Program Presenters
- Evelyn Attia, MD.
- Rachel Shenoi, MD.
- Parisa Sharif.
Program Planners
- Vishal Madaan, MD. Chief of Education and Deputy Medical Director, APA.
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
- The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer 11+
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
- Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
- Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
- Internet Connection: 1 Mbps or higher
Minimum Requirements:
- Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
- Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content
For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance